Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | PRF1 | P14222 | 7/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | TSPO | P30536 | 1/20 | 0.31 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.30 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.30 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13443623 | 0.92 | PDK2 (0.34) | KDM4EATML3MBTL1PRF1PTGER4 | |
| SCHEMBL13443628 | 0.91 | PPARG (0.35) | KDM4EATML3MBTL1PRF1HDAC4 | |
| SCHEMBL12306534 | 0.90 | L3MBTL1 (0.50) | KDM4EATML3MBTL1PTGER4HDAC4 | |
| SCHEMBL13443606 | 0.90 | L3MBTL1 (0.50) | KDM4EATML3MBTL1PTGER4HDAC4 | |
| SCHEMBL13444136 | 0.90 | L3MBTL1 (0.50) | KDM4EATML3MBTL1PTGER4HDAC4 | |
| SCHEMBL13443622 | 0.90 | PRF1 (0.32) | KDM4EATML3MBTL1PRF1MAPT | |
| SCHEMBL13443621 | 0.90 | PRF1 (0.32) | KDM4EATML3MBTL1PRF1 | |
| SCHEMBL13444405 | 0.89 | L3MBTL1 (0.49) | KDM4EATML3MBTL1PTGER4HDAC4 | |
| SCHEMBL13443584 | 0.89 | L3MBTL1 (0.49) | KDM4EATML3MBTL1PTGER4HDAC4 | |
| SCHEMBL13444300 | 0.89 | L3MBTL1 (0.49) | KDM4EATML3MBTL1PTGER4HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100066241-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-18 | — | — | US | disclosed |
| US-20100066241-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-18 | — | — | US | disclosed |
| EP-2138551-A2 | Fluorene-derivatives and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100066241-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | IL33, ORMDL3, CCND3 | KDM4E 4343/4885ATM 4786/4885L3MBTL1 482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.